OBJECTIVES: The introduction of endoscopic saphenous vein harvesting (ESVH) has been reported to decrease saphenectomy-associated wound pain and infection, compared with the traditional open conventional saphenous vein harvesting (OCSVH) technique. Despite all these benefits, the rate of adoption among surgeons has been variable. Criticism of this technique centres on the risk of injury at the time of vein harvest with its potential detrimental effect on structural viability and long-term patency. The aim of our study is to investigate the endothelial preservation of saphenous vein grafts harvested by various extraction methods.
INTRODUCTION
Coronary artery disease (CAD) remains the leading cause of myocardial infarction and sudden cardiac death in the industrialized world [1] . Although mortality from CAD continues to decline in several areas of the world [2] including most countries of Europe, America and Australia, unfavourable trends were still observed in the Russian Federation and other countries of the former Soviet Union, whose recent rates remain exceedingly high [3] .
The initial experience of using saphenous vein segments as coronary bypass conduits was first published from the Cleveland clinic in 1967, where an occluded right coronary artery was reconstructed with an interposition vein graft [4] . Prior to this, case reports of coronary bypass surgery with a vein segment [5] and a 7-year follow-up of a functioning vein graft were reported [6] . The saphenous vein (SV) has a number of practical advantages: it is expendable, since lower limb venous drainage can rely solely on the deep venous system; its long length allows its use for multiple grafts and its superficial position renders it easily accessible, facilitating its exposure at harvest [7] . Since its introduction as a graft, the SV has become the most commonly used conduit in patients undergoing coronary artery bypass grafting (CABG). However, poorer long-term patency rates and clinical outcomes have been reported after CABG performed using SV grafts compared with those after CABG with arterial grafts, such as the internal thoracic artery and right gastroepiploic artery [8] . Our aim is to investigate the histological and immunohistochemical findings of the saphenous vein graft, to rule out endothelial damage as a direct result of manipulation or instrumentation by endoscopic and open conventional harvesting methods.
MATERIALS AND METHODS

Study hypothesis and aims
Mechanical traction and manipulation during endoscopic harvest of saphenous vein grafts may cause structural damage and could result in impaired endothelial function.
Aim 1: histological analysis. To assess the structural viability of saphenous vein endothelium by light microscopy.
Strategy: To perform haematoxylin-eosin staining of human saphenous vein sections and assess endothelial viability.
Aim 2: immunohistochemical analysis. To assess the structural viability of saphenous vein endothelium by immunohistochemistry.
Strategy: Staining human saphenous vein with the CD 31 antibody and assessing the degree of endothelial expression.
STUDY DESIGN
We prospectively analysed 30 human saphenous vein samples from three different treatment groups for this study. The patients were allocated a harvesting technique at the time of listing without any selection bias. Allocations were independent of any patient-related factors such as age, sex, weight, diabetes, peripheral vascular disease etc.
The study protocol was approved by the institutional ethics committee and informed consent was obtained from all study patients. Storage and handling of human tissue was covered by the Human Tissue Act licence held by the institution. Labelling, imaging and image analysis were all done in a blinded fashion. Histology slides and images were independently scored by a senior histology technician and a consultant histopathologist.
Group 1: Open tunnel-endoscopic saphenous vein harvesting (OT-ESVH).
Group 2: Closed tunnel-endoscopic saphenous vein harvesting (CT-ESVH).
Group 3: Open conventional saphenous vein harvesting (OCSVH).
Operative technique
Both endoscopic and open harvesting techniques were performed by a single operator experienced with more than 300 endoscopic saphenous vein harvesting [ESVH (175 OT-ESVH and 125 CT-ESVH)] and 1000 OCSVH cases. All vein samples used for the study were harvested (above knee) from the thigh region and were not distended either during or after preparation to prevent traumatic intraluminal dilatation. We used the Sorin ClearGlide™ Vessel Harvesting
System for all open tunnel endoscopic vein extractions, which is an open carbon dioxide (CO 2 ) system not dependent on gas insufflation to maintain tissue separation. Approximately 6 l/min of CO 2 was continuously insufflated without any pressure in the subcutaneous tunnel. The mean harvesting time of the OT-ESVH technique was 45 min. We used the Maquet VasoView™ Hemopro™ Endoscopic Vessel harvesting system for all closed tunnel vein extractions, which is a closed CO 2 system, designed to create a clear long tunnel view. Approximately 3-5 l/min of CO 2 was continuously insufflated to maintain a pressure of 10-12 mmHg. The mean harvesting time of CT-ESVH was 42 min. For the standard open conventional technique, the SV was exposed by a longitudinal leg incision starting from the medial malleolus and ending at the upper medial thigh at the saphenofemoral junction. The saphenous vein was dissected free from its perivascular fat pedicle and visible side branches were ligated and divided. Direct contact by surgical instruments and distension was avoided to prevent endothelial damage and spasm.
Storage and tissue processing
All samples were immediately immersed after harvesting in saline solution at 4°C, labelled and, at the end of surgery, transported to the research lab for storage in liquid nitrogen until further use. After thawing for 10 min at 37°C, sectioned vein specimens enclosed in labelled tissue processing cassettes were fixed in freshly prepared neutral buffered formalin. This is 10% formalin buffered with sodium dihydrogen phosphate and disodium hydrogen phosphate to pH 7.0, i.e. with Sorenson's buffer. Using this solution ensures that the pH of the fixative remains constant before and during fixation. Bromothymol blue was added to the fixative, as a bluish green pH indicator. The same protocol was followed for all three groups without any significant time difference between harvesting, storage and processing ( 48 h).
Histology and staining
All paraffin embedded samples were sectioned at 5 mm by a Leica 2255 fully automatic rotary microtome. Haematoxylin and eosin staining was performed by a Shandon Varistain™ 24-4 automatic slide stainer to evaluate endothelial preservation. Histologically endothelial viability was classified into three categories: normal endothelium (Grade 0), stretched endothelium (Grade 1) and detached endothelium (Grade 2).
Immunohistochemistry
CD 31 staining was performed using mouse monoclonal antibodies against human endothelial glycoprotein CD31 (1:25, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Endogenous peroxidase activity of the sections was blocked by 10-min preincubation with 3% hydrogen peroxide in methanol. Sections were then incubated in 5% normal goat serum in Tris buffer solution at room temperature for 10 min to block background staining. They were then incubated in mouse monoclonal antibodies against CD31 to evaluate endothelial integrity. The sections were rinsed, and a secondary antibody conjugated with horseradish peroxidase was applied for 30 min. After staining with diaminobenzidine chromogen for 10 min and counterstaining with Mayer's haematoxylin for 15 s, the sections were prepared for microscopic examination. We used the refined scoring system used for immunohistochemical staining [9, 10] . The grading system was dependent on the uptake of staining along the circumference of whole intimal layer. We slightly modified the existing grading system for simplicity. No staining (Grade 1), trace (Grade 2), minimal (Grade 3), moderate (Grade 4) and marked (Grade 5).
Image processing
Both haematoxylin-eosin and immunohistochemistry slides were imaged by Pannoramic 250™ slide scanning system. It has high-NA Carl Zeiss™ optics to achieve maximum resolution of up to 0.16 µm per pixel. Scanned images were sent directly to the University of Manchester Bioimaging server for immediate sharing and analysis. The Pannoramic Viewer™ software was used for efficient image viewing, annotation and archiving.
STATISTICAL ANALYSIS
Statistical package for the social sciences (SPSS) version 20.0 was used for data analysis. Data were expressed as mean ± standard deviation (SD) or proportions. We used one-way analysis of variance to compare the statistical significance between mean values of the three groups. For all analyses, a P-value of ≤0.05 was considered statistically significant.
RESULTS
Histological analysis
The CT-ESVH group showed mostly preserved endothelium (P = 0.398; Fig. 1A , B and D ) with some endothelial stretching (P = 1.0; Fig. 1C ) and no endothelial detachment (P = 0.197). Similarly, OT-ESVH group showed normal endothelium (P = 0.398; Fig. 2A and B) with more endothelial stretching (P = 0.053; Fig. 2C and D) and no endothelial detachment (P = 0.197). However, the OCSVH group showed more endothelial detachment than the other groups (P = 0.01; Fig. 3B ) with normal endothelium in most sections (P = 1.0; Fig. 3A , C and D) and no endothelial stretching (P = 0.073). Bar chart shows endothelial viability (haematoxylineosin staining) by various extraction methods (Fig. 4) .
Immunohistochemical analysis
Immunohistochemistry was performed using antibodies against human endothelial glycoprotein CD31, to assess the degree of staining in the intimal layer. The mean grading score of immunohistochemistry using the CD31 antibody was much lower in the OT-ESVH group (1.6 ± 0.84, P = 0.009, Figs 5 and 6) , showing poorly preserved endothelial cells (ECs), than the CT-ESVH and OCSVH groups. CD31 antibody staining in the CT-ESVH group (3.2 ± 1.23, P = 0.03, Figs 5 and 7) showed better endothelial protection than the rest of the groups and especially when compared with the OT-ESVH group. The OCSVH group (2.6 ± 1.43, P = 0.70; Figs 5 and 8) also showed better endothelial preservation than the OT-ESVH group, but worse than the CT-ESVH group.
DISCUSSION
Our results showed better endothelial preservation with CT-ESVH technique when compared with the OT-ESVH method. However, the OCSVH method revealed poor endothelial protection with areas of endothelial detachment, not observed with both endoscopic methods. Our surgical strategy was to avoid pressure distension of vein grafts, to prevent stretching of the vein wall and vascular smooth muscle cells. This enabled us to investigate the true effect of CO 2 and mechanical trauma inflicted on saphenous vein grafts during harvesting.
ESVH was introduced into cardiac surgical practice to eliminate the need for long skin incisions, and it was associated with fewer wound complications, shorter hospital stays, less postoperative pain and better patient satisfaction [11] . A randomized trial (n = 200) comparing the 6-month patency rate and leg wound complications of endoscopic with open vein harvest, showed reduced leg wound complications in the endoscopic group without compromising the 6-month patency rate [12] . However, a landmark study [13] showed endoscopic vein-graft harvesting independently associated with graft failure and adverse clinical outcomes in a secondary analysis of 3000 patients undergoing CABG (endoscopic: 1753 patients vs open harvesting: 1247 patients). This was a significant finding, resulting in a debate and apprehension among surgeons to use endoscopically harvested vein grafts for coronary artery surgery.
Moreover, CO 2 insufflation used by many endoscopic vein extraction systems facilitates dissection by creating a subcutaneous tunnel. Normally, the insufflated CO 2 is absorbed by the blood and must be eliminated by the lungs through increased ventilation [14] . In the literature, some cases of CO 2 embolisms or hypercarbia during this procedure are described [15, 16] . The mechanism of CO 2 embolism during endoscopic procedures is supposed to be CO 2 absorption or its direct entry, through an injured vessel, into the blood stream.
In our study, we observed more endothelial stretching, without any detachment in the OT-ESVH group, which, in our opinion, was due to lack of tissue separation, poor visualization and traction stresses across the wall of the saphenous vein and its side branches 
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S.F. Hashmi et al. / Interactive CardioVascular and Thoracic Surgeryduring endoscopic handling. The OT-ESVH system used at our institution uses a CO 2 management system that does not occlude CO 2 leaks, but it compensates for the CO 2 losses with additional gas insufflation. There is constant loss of CO 2 from the subcutaneous space through the service hole and the preset maximum gas insufflation pressure of 12 mmHg was rarely reached. This mechanism protects it from thrombosis, without increasing the risk of bleeding from SV side branches. However, the CT-ESVH system maintains a CO 2 pressure of 10-12 mmHg around the vein and avoids gas leaks through the instrument insertion hole with an occluding trocar, thus not allowing the passage of blood flow and hence presents a risk of stasis and thrombosis.
But in our study, even the gas insufflation pressure of up to 12 mmHg in the subcutaneous tunnel (CT-ESVH group) did not affect the vein architecture and no endothelial detachment or disruption was observed. This gives an excellent opportunity to study the true vasomotor function, especially calcium mobilization and eNOS-related NO production. These are known to promote a local vasodilatory effect and prolong graft survival. This protective mechanism was reported in the literature by two studies [17, 18] but they fail to establish the link between CO 2 insufflation and attenuated NO release from the endothelium and the adventitial Vasa Vasorum during endoscopic extraction. We hypothesized that abundance of CO 2 in the subcutaneous tunnel causes this inhibitory effect, which we will try to prove in the next phase of our study.
Both endoscopic methods commonly require bipolar cautery in the vicinity of vein grafts, whereas neither insufflation nor bipolar energy is required for the OCSVH technique. The use of cautery has been proposed to cause thermal injury to the vessel wall, which may impair graft quality by compromising the viability of ECs s, resulting in platelet aggregation and thrombosis. Chronic endothelial damage and dysfunction stimulate migration and proliferation of smooth muscle cells into the intima, a key event in the development of atherosclerosis and SV graft failure [19] . Variable CO 2 pressure in the OT-ESVH method might have exposed the vein graft to traction-induced trauma and vessel spasm. The variability in the intraluminal flow from extrinsic pressure fluctuations may have resulted in increased shear stress and damage to the luminal endothelium. Although both endoscopic methods have similar harvesting times, we found the OT-ESVH method technically more challenging due to lack of optimal visualization. We have used the OCSVH method of harvesting, in which a vein is isolated from its surrounding connective tissue and even in most experienced hands results in trauma and vessel spasm. Recent studies have demonstrated histological differences between conventionally harvested SVs and those harvested using a no-touch surgical technique [20] . The perivascular fat and adventitia (outer vessel wall layer) are generally stripped or damaged during vein harvesting. This plays an important role in graft dysfunction because perivascular fat and adventitia do not merely provide structural support for the media, but also contain a microvascular network responsible for the exchange of gases and supply of nutrients to the vein wall. Periadventitial fat-derived nitric oxide has proved to play a beneficial role in improved SV patency harvested atraumatically by a no-touch technique [21] .
The mean grading score of immunohistochemistry using the CD31 antibody was much lower in the OT-ESVH group, showing poorly preserved ECs, than the rest of the groups. The OCSVH group showed better endothelial preservation than the OT-ESVH group, but worse than the CT-ESVH group, although this was not statistically significant.
In our study, among the endoscopic groups, the CT-ESVH method showed the highest CD31 antibody grading scores, with 50% more staining in the intimal layer. ECs constitute not only a barrier between blood and extracellular matrix but also a source of molecules that influence both the structural and functional integrity of vessel wall permeability and circulation. They secrete a wide spectrum of molecules into the blood as well as to the subendothelial extracellular matrix. These molecules are involved in the formation of platelet and fibrin thrombi [e.g. von Willebrand factor (vWF) and tissue factors], contribute to antithrombotic properties of the endothelium (e.g. prostacyclin, thrombomodulin and heparan sulphate), express plasminogen activators and inhibitors, regulate growth of other cells, bind lipoproteins and hormones and are involved in immune reactions [22] . CD31 is found in large amounts on ECs and is less abundant on platelets and most leucocytes. It plays a major role in a number of cellular interactions, most notably in the adhesion cascade between ECs and polymorphonuclear leucocytes, monocytes and lymphocytes (by heterophilic cell interactions) in inflammatory processes and between adjacent ECs (by homophilic cell interactions) during the process of angiogenesis [23] . CD31 is one of the most commonly used endothelial marker for assessing endothelial structural integrity. Previous studies have reported that CD31 was strongly and homogeneously expressed in pulmonary vascular endothelial tissue [24] . Another study reported that the expression of EC markers CD31, CD34 and vWF in the vascular tree was heterogeneous, with specific patterns for individual vessel types and different anatomical compartments of the same organ [15] . The staining pattern of large veins like the inferior vena, pulmonary and femoral vein showed continuous and strong staining for vWF. The staining pattern was usually discontinuous for CD31 and CD34, the intensity being less for vWF. CD34 also stained some components of the media, probably corresponding to smooth muscle cells [25] . There are limited data available on the immunohistochemical expression pattern of CD31 in saphenous vein endothelium and we observed a similar discontinuous staining pattern of ECs and smooth muscle cells in our study. Poor endothelial preservation reflected by weak CD31 staining in our OT-ESVH group supports the idea of traction-induced injury by endoscopic manipulation. Similar results were observed by haematoxylin-eosin staining from the same group, showing endothelial stretching. These histological findings should be interpreted with caution, as we have examined only the histological features and staining patterns of the vein, which may not reflect the true effects of CO 2 insufflation and thermal damage on the vasomotor function of the SV graft, which need to be further investigated. We believe that damage to the segments of the saphenous vein harvested either by open or an endoscopic method is inevitable, but by mastering less traumatic harvesting techniques, improved graft patency and function may be achieved.
